Non-THC CBD oils can be highly effective, and are suitable for employees who face random or routine drug tests. Our top pick for this category is the Medterra CBD Oil Tincture, which contains 99.6% CBD and MCT oil (also known as coconut oil extract) without any traces of THC. The oil is derived from hemp plants that are free of GMOs and pesticides, as well. All third-party testing results for the oil are accessible through Medterra’s official product page.
The CBD oil products generally have a shelf life of at least one year, if stored in a cool, dark place. Refrigeration is typically not necessary as long as it is kept somewhere where the temperature is less than 77 degrees Fahrenheit. Tinctures that use MCT coconut oil as the carrier oil are known to have a longer shelf life than those with hemp seed oil as the carrier oil.
Customer Service: It’s difficult to find contact information on Calm by Wellness’s website, and their email address is listed incorrectly in two places (we tried sending them an email but it was not delivered). We were, however, able to get a response through Facebook, and the company does offer free shipping and a generous 30-day return policy on all orders.
‘In the 1940s and early 1950s, further studies showed inactivation of diverse bacteria, influenza virus, and Penicillium chrysogenum (previously P. notatum) mold fungus using various glycols, principally propylene glycol and triethylene glycol. In principle, these chemical substances are ideal air disinfectants because they have both high lethality to microorganisms and low mammalian toxicity.’
As mentioned above, CBD is no longer considered a Schedule I controlled substance under the Farm Act. However, under the DEA’s definition, it remains on the list. This allows for individual states to create exceptions to the status of CBD, even when cultivated from hemp plants grown legally under the act. It also maintains illegal status for any CBD sourced from plants produced in settings that are not consistent with that Act, or by an unlicensed grower. It is expected that more clarification on the status of CBD will come early this year (2019).